8th CAR-TCR Europe Summit

Date : 25th February 2025 to 27th February 2025

Place : United Kingdom, London

Website :http://go.evvnt.com/2712222-0?pid=80

Contact Person:Clarice Handley

Description:

Enhance Engineering to Improve Durability and Cell Function, with Advanced Manufacturability to Consistently Develop Affordable, Efficacious Cell Therapies. Time: 8:00 am to 5:30 pm. Prices: GBP 2199.00 - GBP 5097.00.

8th CAR-TCR Europe Summit will be held in London,United Kingdom on date 2025-02-27

---

Deadline for abstracts/proposals : 25th February 2025

Keynote Speakers :

Conference Highlights :8th CAR-TCR Summit Europe
Join 300+ experts at CAR-TCR London - the only cell therapy conference helping to develop clinically durable & cost-effective cell therapies.

Investors in the cell therapy industry are actively looking into solid tumours, autoimmune indications and novel engineering as the best place to allocate their money and resources. This, along with the recent investments inEnara Bio,ArsenalBio,KyvernaandArtivasignifies that the field is poised to regain momentum.
It’s not just investments that are gaining traction. Recent approvals are changing the game, withIovanceandAdaptimmunemaking strides in treating solid tumours,Kitesecuring first-line treatment approval, and donor cell therapies, demonstrating success in putting autoimmune diseases into remission. The industry is brimming with new hope!
The8th CAR-TCR Summit Europereturns to London this February as your must-attend forum to remain on the pulse of recent innovation in cell therapy. Join us to collaborate, innovate, and overcome the shared challenges ofsafety concerns,high cost of goods,effective tumour targeting, and more. Let’s work together todrive success in clinical trials,secure regulatory approvals, andposition cell therapy as the first-line treatmentfor oncological and non-oncological indications.
Autoimmune Focus Day
Cabaletta Bio,GentiBioandCullinan Therapeuticsare leading the charge in autoimmune indications. Join them to benchmark your approaches, and ask your pressing questions on choosing disease targets, navigating safety concerns, and improving durablity of response to capitalise on the future of cell therapy

Check the event website for more details.